Peptide Kappa Opioid Receptor Ligands and Their Potential for Drug Development | SpringerLink
Frontiers | Advances in Achieving Opioid Analgesia Without Side Effects
Peripheral kappa opioid receptor activation drives cold hypersensitivity in mice | bioRxiv
New Kappa-Opioid Receptor Agonist Curbs Pain, Avoids Side Effects
New Kappa-Opioid Receptor Agonist Curbs Pain, Avoids Side Effects
Difelikefalin - Wikipedia
Peptide Kappa Opioid Receptor Ligands and Their Potential for Drug Development | SpringerLink
Cara Therapeutics: Scratching An Itch Left Unscratched (NASDAQ:CARA) | Seeking Alpha
1Washington University, St. Louis, MO, USA; 2Trevi Therapeutics, New Haven, CT, USA; 3University of Miami, Miami, FL, USA Introd
Will peripherally restricted kappa‐opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential? - Albert‐Vartanian - 2016 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
Experimental Kappa Opioid Appears Safe and Effective
Cara Therapeutics: Scratching At Multiple Indications In 2020 (NASDAQ:CARA) | Seeking Alpha
EX-99.2
Pharmaceuticals | Free Full-Text | Therapeutic Potential of Kappa Opioid Agonists
CR845 (Difelikefalin), A Kappa Receptors Agonist In Phase III By CARA Therapeutics: A Case Of 'Spin' In Scientific Writing? | Semantic Scholar
Articles with Cara Therapeutics, Inc. | page 5
New Kappa-Opioid Receptor Agonist Curbs Pain, Avoids Side Effects
Cara Therapeutics: Developing Novel Peripheral Kappa Opioid Product Candidates
Effect of difelikefalin, a selective kappa opioid receptor agonist, on respiratory depression<b>:</b> A randomized,
Strategies for Developing κ Opioid Receptor Agonists for the Treatment of Pain with Fewer Side Effects | Journal of Pharmacology and Experimental Therapeutics
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
κ-opioid receptor - Wikipedia
A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus | NEJM
Kappa-opioid receptor-dependent changes in dopamine and anxiety-like or approach-avoidance behavior occur differentially across the nucleus accumbens shell rostro-caudal axis,Neuropharmacology - X-MOL
